Turn Therapeutics

Contributing Author

Recent Articles by Turn Therapeutics

Jan-07	Turn Therapeutics Appoints Martin Dewhurst to its Board of Directors TTRX GlobeNewswire
Nov-13	Turn Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Updates TTRX GlobeNewswire
Nov-11	Turn Therapeutics CEO, Bradley Burnam, Speaks with Former Director of the Centers for Disease Control and Prevention Dr. Robert Redfield, M.D. TTRX GlobeNewswire
Nov-11	Turn Therapeutics' GX-03 Technology Named as One of "Five Novel Mechanisms Reshaping Atopic Dermatitis Treatment" by Patient Care Online Magazine TTRX GlobeNewswire
Nov-04	Turn Therapeutics Appoints Veteran Capital Markets Executive Andrew Scott as Vice President of Corporate Communications TTRX GlobeNewswire
Oct-30	Turn Therapeutics Enters Global Supply, Development, and License Agreement with Leading Medical-Surgical Product Manufacturer and Distributor Medline TTRX GlobeNewswire
Oct-22	Turn Therapeutics Provides Shareholder Update Highlighting Continued Execution Across Clinical and Strategic Milestones TTRX GlobeNewswire
Oct-20	Turn Therapeutics Launches Webinar Series for Ongoing Shareholder Engagement, First Session October 22, 2025 TTRX GlobeNewswire
Oct-15	Turn Therapeutics Appoints Dr. Kent Kester to Board of Directors TTRX GlobeNewswire
Oct-14	Turn Therapeutics Appoints Arthur Golden to Board of Directors TTRX GlobeNewswire
Oct-08	Turn Therapeutics to Commence Trading Today on Nasdaq TTRX GlobeNewswire